// App-Quantinova.ai

: Antithrombin III Replacement in a Premature Infant with an Occlusive Inferior Vena Cava Thromboembolism on Low Molecular Weight Heparin: Is There a Target Antithrombin III Activity?

Researchers

Presenter

  • A. Shukla

Principal Investigators

  • C. Braunreiter

Medical Centers

  • Helen DeVos Children's Hospital at Spectrum Health, Grand Rapids, MI

  • Michigan State University, Department of Pediatrics and Human Development, East Lansing, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Venous thrombosis

Biomarkers

  • Antithrombin III

Drug/Treatment

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved